Advertisement
Canada markets close in 2 hours 19 minutes
  • S&P/TSX

    21,972.97
    +87.59 (+0.40%)
     
  • S&P 500

    5,108.45
    +60.03 (+1.19%)
     
  • DOW

    38,296.19
    +210.39 (+0.55%)
     
  • CAD/USD

    0.7314
    -0.0009 (-0.13%)
     
  • CRUDE OIL

    83.81
    +0.24 (+0.29%)
     
  • Bitcoin CAD

    87,349.55
    -1,029.88 (-1.17%)
     
  • CMC Crypto 200

    1,327.17
    -69.37 (-4.77%)
     
  • GOLD FUTURES

    2,346.80
    +4.30 (+0.18%)
     
  • RUSSELL 2000

    2,004.67
    +23.55 (+1.19%)
     
  • 10-Yr Bond

    4.6770
    -0.0290 (-0.62%)
     
  • NASDAQ

    15,952.36
    +340.60 (+2.18%)
     
  • VOLATILITY

    15.05
    -0.32 (-2.08%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Amazon expands Prime Now; Mattel's American Girl signs deal with Toys 'R' Us; Veeva Systems beats earnings expectations

Yahoo Finance is tracking the stocks you’re following, based on your Yahoo Finance ticker searches.

Amazon (AMZN) – The e-commerce giant is boosting its Prime Now same-day delivery options. Amazon announced that it will now offer free one-hour restaurant delivery to its Prime customers in Houston.

Mattel (MAT) – The company has reached an exclusive agreement with Toys “R” Us to set up American Girl shops inside certain stores. Toys “R” Us will be the exclusive seller of the Truly Me American Girl line.

Veeva Systems (VEEV) – The company posted second-quarter fiscal year 2017 revenue of $131.3 million, up 34% year-over-year. Veeva Systems updated its fiscal year 2017 projections for revenue to $525 million to $528 million and earnings per share to 60 cents to 61 cents.

ADVERTISEMENT

AstraZeneca (AZN) – US regulators say AstraZeneca will pay $5.5 million to settle a foreign bribery probe at the drug maker’s Chinese and Russian units. The company is accused of making payments and giving gifts to state-employed health care workers in return for more prescriptions.

Dollar General (DG) – The discount retailer was downgraded to neutral from overweight at Atlantic Equities. The firm lowered its price target on the stock to $78 from $99, warning that its lacks near-term transparency.